In recent years, fibroblast growth factor 23 (FGF23) has gained wide attention in many fields of medicine and has become a promising biomarker linking chronic kidney disease (CKD) with CV morbidity and mortality [18,19]. The gene discussed is FGF23; the disease is chronic kidney disease.